Henry Schein, HSIC

Henry Schein stock: company announces conference presentation and distribution agreement

Published on 09/29/2026 at 19:11 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS

Henry Schein announced a scheduled presentation at the Baird Global Healthcare Conference. Separately, the company agreed to distribute Applied BioCode’s molecular diagnostics system and assays.

Moderne Zahnarztpraxis mit Behandlungsstuhl und medizinischen Instrumenten, Henry Schein Sektor
Henry Schein US42548G1040 versorgt Zahnarztpraxen weltweit mit hochwertigen medizinischen Produkten und Dentalgeräten, Illustration mit AI erstellt.

Business Wire reported that Henry Schein, Inc. (Nasdaq: HSIC) announced plans to present at the Baird Global Healthcare Conference on September 15, 2026, at 12:15 p.m. EDT at the InterContinental Hotel in New York City. The company said the presentation would be available by live webcast, with a replay to follow on its website.

Distribution agreement

Business Wire reported that Applied BioCode announced a distribution agreement with Henry Schein. Under the agreement, Henry Schein will distribute Applied BioCode’s BioCode MDx-3000 System and associated assays to hospitals, health systems and reference laboratories nationwide.

Disclaimer...

en | boerse | 70199977 |